The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

Apr. 12, 2018
Applicants:

Eth Zurich, Zürich, CH;

Universität Zürich, Zürich, CH;

Inventors:

Christophe Lacroix, Kilchberg, CH;

Tomas De Wouters, Zürich, CH;

Gerhard Rogler, Zürich, CH;

Christophe Chassard, Lempdes, FR;

Laura Berchtold, Stalden, CH;

Fabienne Kurt, Zürich, CH;

Michael Martin Scharl, Aesch, CH;

Marianne Rebecca Spalinger, Staufen, CH;

Markus Reichlin, Winterthur, CH;

Florian Nils Rosenthal, Zürich, CH;

Marco Meola, Affoltern am Albis, CH;

Assignees:

ETH Zurich, Zürich, CH;

UNIVERSITÄT ZÜRICH, Zürich, CH;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/745 (2015.01); A61P 1/00 (2006.01); A61K 35/742 (2015.01); A61K 35/747 (2015.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/745 (2013.01); A61K 35/742 (2013.01); A61K 35/747 (2013.01); A61P 1/00 (2018.01); A61K 9/0031 (2013.01); A61K 9/0053 (2013.01);
Abstract

The present invention relates to novel compositions comprising specific consortia of living bacteria strains; to the manufacturing of such compositions, particularly by co-cultivation; and to the use of such compositions in pharmaceutical applications, such as the treatment of diseases associated with intestinal microbiota dysbiosis, particularly intestinal infections such as CDI (infection) and IBD (Inflammatory bowel diseases). When compared to the traditional FMT therapy () the inventive compositions () are more efficient and safer as demonstrated on an acute colitis model and therefore more appropriate for therapeutic use.


Find Patent Forward Citations

Lacroix, Christophe. (2022). Consortia of living bacteria useful for treatment of microbiome dysbiosis (U.S. Patent No. 11219649). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11219649

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…